Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

China · Delayed Price · Currency is CNY

57.86

+1.04 (1.83%)

At close: Apr 16, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	1.33B	1.03B	798.47M	524.37M	379.44M
Pharmaceuticals Growth	29.53%	28.39%	52.27%	38.20%	12.16%
Total	1.33B	1.03B	798.47M	524.37M	379.44M
Total Growth	29.53%	28.39%	52.27%	38.20%	12.16%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China	1.30B	992.40M	792.46M	520.83M	379.44M
China Growth	30.86%	25.23%	52.15%	37.26%	12.23%
Overseas	29.27M	32.75M	6.01M	3.54M	-
Overseas Growth	-10.63%	445.10%	69.49%	-	-
Total	1.33B	1.03B	798.47M	524.37M	379.44M
Total Growth	29.53%	28.39%	52.27%	38.20%	12.16%

Source: S&P Global Market Intelligence.